Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity,
and
microbiota
could
play
key
role
the
infection,
progression,
outcome
of
disease.
SARS-CoV-2
infection
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.
To
identify
new
prognostic
markers
for
disease,
multicenter
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
divided
into
three
cohorts
based
on
symptomatology:
mild
(n=24),
moderate
(n=51),
severe/critical
(n=31).
Faecal
samples
were
taken,
analyzed.
Linear
discriminant
analysis
identified
M.
salivarium
,
P.
dentalis
H.
parainfluenzae
as
biomarkers
microbiota,
while
bivia
timonensis
defined
faecal
microbiota.
Additionally,
connection
between
identified,
significant
ratio
(faeces)
(nasopharyngeal)
abundances
found
critically
ill
patients.
This
serve
novel
tool
identifying
cases.
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity,
and
microbiota
could
play
key
role
the
infection,
progression,
outcome
of
disease.
SARS-CoV-2
infection
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.
To
identify
new
prognostic
markers
for
disease,
multicentre
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
divided
into
three
cohorts
based
on
symptomatology:
mild
(n
=
24),
moderate
51),
severe/critical
31).
Faecal
samples
were
taken,
analysed.
Linear
discriminant
analysis
identified
Mycoplasma
salivarium
,
Prevotella
dentalis
Haemophilus
parainfluenzae
as
biomarkers
microbiota,
while
bivia
timonensis
defined
faecal
microbiota.
Additionally,
connection
between
identified,
significant
ratio
P.
(faeces)
M.
(nasopharyngeal)
abundances
found
critically
ill
patients.
This
serve
novel
tool
identifying
cases.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 13, 2024
ABSTRACT
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity,
and
microbiota
could
play
key
role
the
infection,
progression,
outcome
of
disease.
SARS-CoV-2
infection
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.
To
identify
new
prognostic
markers
for
disease,
multicenter
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
divided
into
three
cohorts
based
on
symptomatology:
mild
(n=24),
moderate
(n=51),
severe/critical
(n=31).
Faecal
samples
were
taken,
analyzed.
Linear
discriminant
analysis
identified
M.
salivarium
,
P.
dentalis
H.
parainfluenzae
as
biomarkers
microbiota,
while
bivia
timonensis
defined
faecal
microbiota.
Additionally,
connection
between
identified,
significant
ratio
(faeces)
(nasopharyngeal)
abundances
found
critically
ill
patients.
This
serve
novel
tool
identifying
cases.
STAR Protocols,
Год журнала:
2024,
Номер
5(2), С. 103071 - 103071
Опубликована: Май 19, 2024
The
elucidation
of
the
role
microorganisms
in
human
infections
has
been
hindered
by
difficulties
using
conventional
culture-based
techniques.
Here,
we
present
a
protocol
for
investigation
transcriptionally
active
microbes
(TAMs)
an
RNA
sequencing
(RNA-seq)-based
approach.
We
describe
steps
isolation,
viral
genome
sequencing,
RNA-seq
library
preparation,
and
metatranscriptomic
transcriptomic
analysis.
This
permits
comprehensive
evaluation
TAMs'
contributions
to
differential
severity
infectious
diseases,
with
particular
focus
on
diseases
such
as
COVID-19.
For
complete
details
use
execution
this
protocol,
please
refer
Devi
et
al.1
PLoS neglected tropical diseases,
Год журнала:
2024,
Номер
18(10), С. e0012589 - e0012589
Опубликована: Окт. 17, 2024
Background
Dengue
is
the
most
re-emergent
infection,
with
approximately
100
million
new
cases
reported
annually,
yet
no
effective
treatment
or
vaccine
exists.
Here,
we
aim
to
define
microbial
community
structure
and
their
functional
profiles
in
dengue
positive
patients
varying
disease
severity.
Methodology/Principal
findings
Hospital
admitted
112
dengue-positive
blood
samples
were
analyzed
by
dual
RNA-sequencing
simultaneously
identify
transcriptionally
active
microbes
(TAMs),
expressed
genes
associated
pathways.
Results
highlight
that
severe
exhibited
increased
diversity
presence
of
opportunistic
species
(unique
core)
which
includes
Bacillus
cereus
,
Burkholderia
pseudomallei
Streptococcus
suis
Serratia
marcescens
.
The
profile
analysis
revealed
enriched
metabolic
pathways
such
as
protein
degradation,
nucleotide
biosynthesis,
ion
transport,
cell
shape
integrity,
ATP
formation
cases,
indicating
high
energy
demands
adaptability
these
microbes.
Conclusion
Our
metatranscriptomic
approach
provides
a
species-level
characterization
microbiome
composition
reveals
heightened
TAMs
dengue,
underscoring
need
for
further
research
into
role
microbiota
progression.
Comparing
signatures
across
severity
classes
early
offers
unique
potential
convenient
diagnosis
infection.
Frontiers in Microbiology,
Год журнала:
2023,
Номер
14
Опубликована: Ноя. 30, 2023
Introduction
Dengue
virus
(DENV)
is
a
flavivirus
that
has
emerged
as
global
health
threat,
characterized
by
either
asymptomatic
or
mild
self-limiting
febrile
illness,
but
subset
of
DENV
outbreaks
have
been
associated
with
severe
disease.
Studies
looked
into
the
host
immune
response
and
dengue
viral
load
during
infection.
However,
it
remains
unknown
how
active
microbial
isolates
modulate
In
this
study,
we
demonstrate
significance
in-depth
analysis
microbiota
composition
in
serum
samples
dengue-infected
patients.
Materials
methods
RNA
was
extracted
from
collected
24
positive
The
human
mapped
reads
generated
through
RNA-Sequencing
(RNA-Seq)
were
removed,
while
unmapped
(non-human)
employed
for
taxonomic
classification
using
Kraken2
Bracken2.
Further,
assessed
initial
blood
parameters
analyzing
complete
count
(CBC)
profile
Results
Findings
revealed
differential
abundance
commensals
pathogenic
microbes
early
period
hospitalized
patients,
segregated
into,
High
Viral
Reads
(HVR)
Low
(LVR).
Campylobacter
genus
abundant
HVR
whereas
Lactobacillus
dominated
LVR
At
species
level,
exhibited
higher
unique
potential
opportunistic
microbes,
compared
to
commensal
microbes’
enrichment
patients’.
We
hypothesize
might
alter
observed
increase
preponderance
pathogens
an
absence
HVR.
presence
explain,
i)
overall
lower
HVR,
ii)
shift
lymphocytes
(high)
neutrophils
(low)
counts;
resulting
comparatively
milder
clinical
manifestation
group.
Our
findings
may
help
understanding
co-infection
aspect
will
be
important
develop
therapeutics
vaccines.
Discussion
This
study
highlights
unexplored
roles
TAMs
modulating
disease
severity
metatranscriptomic
sequencing.
serves
enhance
our
distinctive
hematologic
signatures
infection
stage
differentiate
patients
high
those
low
reads.
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity,
and
microbiota
could
play
key
role
the
infection,
progression,
outcome
of
disease.
SARS-CoV-2
infection
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.
To
identify
new
prognostic
markers
for
disease,
multicentre
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
divided
into
three
cohorts
based
on
symptomatology:
mild
(n
=
24),
moderate
51),
severe/critical
31).
Faecal
samples
were
taken,
analysed.
Linear
discriminant
analysis
identified
Mycoplasma
salivarium,
Prevotella
dentalis,
Haemophilus
parainfluenzae
as
biomarkers
microbiota,
while
bivia
timonensis
defined
faecal
microbiota.
Additionally,
connection
between
identified,
significant
ratio
P.
(faeces)
dentalis
M.
salivarium
(nasopharyngeal)
abundances
found
critically
ill
patients.
This
serve
novel
tool
identifying
cases.
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity
but
no
specific
determinants
of
infection
outcome
identified
yet,
maybe
due
the
complex
pathogenic
mechanisms.
The
microbiota
could
play
key
role
and
progression
disease.
Hence,
SARS-CoV-2
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.To
identify
new
prognostic
markers
for
disease,
multicenter
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
were
divided
three
cohorts
according
their
symptomatology:
mild
(n=24),
moderate
(n=51)
severe/critical
(n=31).
Faecal
samples
taken
analysed.Microbiota
composition
symptoms
linear
discriminant
analysis
genera
Mycoplasma
Prevotella
as
biomarkers
samples,
Allistipes
,
Enterococcus
Escherichia
faecal
samples.
Moreover,
M.
salivarium
defined
unique
microorganism
patients’
while
P.
bivia
timonensis
microbiota.
A
connection
between
also
strong
positive
correlation
(faeces)
towards
dentalis
(nasopharyngeal)
found
critically
ill
patients.This
ratio
used
novel
biomarker
patients.